Drug ID: | NPD5588 |
Drug Name: | Empagliflozin |
Molecular Formula: | C23H27ClO7 |
Canonical SMILES: | OC[C@H]1O[C@@H](c2ccc(c(c2)Cc2ccc(cc2)O[C@@H]2COCC2)Cl)[C@@H]([C@H]([C@@H]1O)O)O |
Standard InCHI: | InChI=1S/C23H27ClO7/c24-18-6-3-14(23-22(28)21(27)20(26)19(11-25)31-23)10-15(18)9-13-1-4-16(5-2-13)30-17-7-8-29-12-17/h1-6,10,17,19-23,25-28H,7-9,11-12H2/t17-,19+,20+,21-,22+,23-/m0/s1 |
Standard InCHIKey: | OBWASQILIWPZMG-QZMOQZSNSA-N |
Max Developmental Stage: | Approved |
Max Developmental Stage Source: | TTD; ChEMBL; IUPHAR/BPS |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DNCL002850; DNCL002851; DNCL002852 |
DrugBank | DB09038 |
ChEMBL | CHEMBL2107830 |
IUPHAR/BPS | 4754 |
PharmaGKB | |
KEGG Drug | D10459 |
PubChem CID | 11949646 |
ChEBI | 82720 |
CAS Number | 864070-44-0 |
Molecular Weight | 450.14 |
ALogP | -1.6586 |
MLogP | 3.11 |
XLogP | 2.901 |
HDA | 6 |
HBD | 4 |
Rotatable Bonds | 11 |
TPSA | 108.61 |
RO5 Violation | 0 |